Position in GMAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$44,780,518
-$13,835,005 QoQ
Shares Held
1,630,161
-25.4% QoQ
Ownership
0.265%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 292 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 79%
Shared 0%
None 21%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. GMAB ranks #62 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
42,931,597 | $2,407,174,637 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,242,139 | $1,610,467,694 | |
| 3 | ROIV |
Roivant Sciences Ltd.
|
42,592,905 | $1,507,362,901 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,397,712 | $871,529,332 | |
| 5 | MRNA |
Moderna, Inc.
|
9,538,094 | $667,952,718 | |
| 6 | ARGX |
Argenx SE
|
643,123 | $596,670,219 | |
| 7 | TECH |
BIO-TECHNE Corp
|
6,374,717 | $450,373,747 | |
| 8 | INCY |
Incyte Corp
|
2,948,364 | $334,226,536 |
All Filings in GMAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,780,518 | 1,630,161 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $58,615,523 | 2,184,701 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $56,500,719 | 1,834,439 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $51,359,180 | 1,674,574 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $55,722,803 | 2,697,135 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $55,586,205 | 2,838,928 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $58,558,731 | 2,805,881 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $39,992,705 | 1,640,390 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $25,868,240 | 1,029,377 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $29,133,413 | 974,036 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $34,676,845 | 1,089,097 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $38,815,302 | 1,100,519 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $38,347,525 | 1,008,880 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $40,652,111 | 1,076,592 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $51,528,187 | 1,215,861 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $27,890,026 | 868,037 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $23,669,123 | 728,505 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,820,715 | 105,603 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $5,650,510 | 142,834 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,712,349 | 176,484 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,901,109 | 242,496 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $12,019,815 | 366,123 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $21,803,598 | 536,242 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $31,505,868 | 860,581 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $43,422,611 | 1,281,281 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,690,787 | 221,368 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||